What is the appropriate management for a patient with complicated gallbladder disease and a cholecysto-enteric fistula?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Complicated Gallbladder Disease with Cholecystoenteric Fistula

This 65-year-old male with Type III gallbladder perforation (cholecystoenteric fistula) involving the hepatic flexure and duodenum, along with suspected liver abscesses, requires immediate broad-spectrum antibiotics, percutaneous drainage of fluid collections if present, and referral to a hepatobiliary center for definitive surgical management with cholecystectomy and fistula repair once the acute inflammatory process is controlled.

Immediate Management: Source Control and Stabilization

Antibiotic Therapy - Start Within 1 Hour

  • Initiate piperacillin/tazobactam 6g/0.75g loading dose, then 4g/0.5g every 6 hours (or 16g/2g continuous infusion) immediately, as this patient has complicated cholecystitis with fistula formation and suspected liver abscesses 1.

  • For beta-lactam allergy, use eravacycline 1 mg/kg every 12 hours OR tigecycline 100 mg loading dose then 50 mg every 12 hours 2.

  • Continue antibiotics for up to 7 days based on clinical response and inflammatory markers (CRP, PCT, lactate), as this patient is elderly with complicated disease 1, 2.

Percutaneous Drainage

  • Perform CT-guided percutaneous drainage of the peripherally enhancing hypodense liver lesions (suspected abscesses measuring up to 17×15 mm), as source control is the priority in complicated biliary infections 1.

  • If periportal or pericaval necrotic lymph nodes represent fluid collections, these should also be drained percutaneously 1.

Classification and Surgical Planning

Understanding the Pathology

  • This patient has Type III gallbladder perforation (chronic cholecystoenteric fistula), which typically occurs in elderly patients with recurrent cholecystitis 1.

  • The imaging demonstrates multiple fistulous communications: cholecystocolic fistula to hepatic flexure and cholecystoduodenal fistula to the second part of duodenum, with a large 32mm impacted stone causing Mirizzi-like syndrome 3, 4.

  • Pneumobilia (air in bile ducts and gallbladder) confirms the presence of bilioenteric communication 4.

Timing of Definitive Surgery

Do NOT operate immediately. The 2020 WSES guidelines provide clear direction:

  • Wait minimum 3 weeks after initial stabilization before attempting definitive surgical repair 1.

  • During this waiting period: continue targeted antibiotics, provide nutritional support, and monitor for resolution of acute inflammation 1.

  • ERCP with sphincterotomy ± stent placement can be considered during this period to reduce biliary tree pressure, though the existing fistulas may already decompress the system 1.

Definitive Surgical Management

Referral to Hepatobiliary Center

  • Immediate referral to a center with hepatopancreatobiliary (HPB) expertise is mandatory, as this complex case involves liver infiltration, dual fistulas, and potential malignancy (given the liver lesions) 1.

  • Delayed surgical intervention after acute inflammation resolves is associated with better outcomes than emergency surgery in Type III perforations 1.

Surgical Approach

  • Open cholecystectomy with fistula takedown and repair is the procedure of choice, as laparoscopic approach is contraindicated given the extensive inflammation, liver infiltration, and dual fistulous communications 1, 5.

  • The surgery should include: cholecystectomy, fistula tract excision, primary repair of duodenum and colon, and assessment of the common bile duct for stones 3, 5.

  • One-stage procedure (cholecystectomy + fistula repair) should be performed once inflammation resolves, rather than simple fistula takedown alone 5.

  • Intraoperative cholangiography or bile duct exploration may be necessary given the pneumobilia and large impacted stone 3.

Critical Pitfalls to Avoid

Do Not Delay Initial Stabilization

  • Mortality in gallbladder perforation is 12-16%, making immediate antibiotic therapy and source control (drainage) essential 1.

  • The presence of necrotic lymph nodes and liver lesions suggests ongoing septic process requiring urgent intervention 1.

Do Not Rush to Surgery

  • Operating during acute inflammation (within 72 hours to 3 weeks) significantly increases morbidity in Type III perforations 1.

  • The extensive infiltration into liver segment V, hepatic flexure, and duodenum makes emergency surgery extremely hazardous 1.

Do Not Miss Malignancy

  • The multiple liver lesions require tissue diagnosis - these could represent cholangiolytic abscesses OR metastatic gallbladder carcinoma 1.

  • Gallbladder cancer can present identically to complicated cholecystitis with fistula formation 3.

  • If biopsies suggest malignancy, the surgical approach changes entirely to oncologic resection 3.

Do Not Underestimate Nutritional Support

  • Cholecystoenteric fistulas cause chronic bile loss and malabsorption, requiring aggressive nutritional supplementation during the waiting period 1.

  • Consider nasojejunal feeding if oral intake is inadequate 6.

Monitoring During Waiting Period

  • Serial inflammatory markers (CRP, PCT, WBC) every 2-3 days to confirm resolution of acute inflammation 1.

  • Repeat imaging at 2-3 weeks to assess resolution of liver abscesses and pericholecystic inflammation before surgery 1.

  • Blood cultures if fever persists beyond 48-72 hours of appropriate antibiotics, suggesting inadequate source control 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Prophylaxis in Cholecystitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cholecystocolonic fistula: A rare case report of Mirizzi syndrome.

International journal of surgery case reports, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.